Isolated HLA-C mismatches in unrelated donor transplantation for CML

[1]  L. Moretta,et al.  Killer immunoglobulin-like receptors. , 2004, Current opinion in immunology.

[2]  F. Christiansen,et al.  The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. , 2004, Tissue antigens.

[3]  M. Remberger,et al.  Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. , 2003, Tissue antigens.

[4]  J. Madrigal,et al.  The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.

[5]  Daniel J Weisdorf,et al.  Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. , 2002, Blood.

[6]  J. Tiercy,et al.  Selection of unrelated bone marrow donors by serology, molecular typing and cellular assays. , 2002, Transplant immunology.

[7]  H. Inoko,et al.  The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.

[8]  C. Kollman,et al.  Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. , 2002, Blood.

[9]  J. Klein,et al.  Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alt , 2002, Blood.

[10]  B. Storer,et al.  Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. , 2001, The New England journal of medicine.

[11]  A. Nademanee,et al.  Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. , 2001, Blood.

[12]  I. Joosten,et al.  HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity. , 2001, Transplantation.

[13]  J. Tiercy,et al.  Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor? , 2000, Bone Marrow Transplantation.

[14]  J. Tiercy,et al.  Search for an unrelated HLA-compatible stem cell donor. , 1999, Current opinion in hematology.

[15]  A. Tosti,et al.  Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. , 1999, Blood.

[16]  G. Heller,et al.  DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. , 1999, Blood.

[17]  Anajane G. Smith,et al.  Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.

[18]  Takato O. Yoshida,et al.  EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .

[19]  Lamparelli,et al.  Unrelated donor marrow transplantation for chronic myelogenous leukaemia , 1998, British journal of haematology.

[20]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[21]  M. Bunce,et al.  Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. , 1998, Blood.

[22]  G. Longton,et al.  Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. , 1997, Blood.

[23]  C. Brautbar,et al.  Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity. , 1996, Bone marrow transplantation.

[24]  D. Speiser,et al.  High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. , 1996, Blood.

[25]  D. Speiser,et al.  Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. , 1995, Bone marrow transplantation.

[26]  J. Goldman,et al.  Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient. , 1995, Blood.

[27]  G. Longton,et al.  The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. , 1995, Blood.

[28]  P. Parham,et al.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA , 1995, The Journal of experimental medicine.

[29]  M. Boyce-Jacino,et al.  Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. , 1994, Blood.

[30]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[31]  Pepe,et al.  Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. , 1993, Blood.